Neutralizing human anti-IGFR antibody
The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
Schering Corporation
A C C A C C A C A C A A A C C A
A61P C07K C07K A61K C07K C07K A61P C07K A61P C07K A61P A61P A61P C07K C07K A61P
inventional additional additional additional additional additional inventional inventional inventional additional inventional inventional inventional inventional additional inventional
Jonathan A. Yan Robert Mohan Judith Denise Leonard Peter Diane
Pachter Wang Greenberg Srinivasan Hailey Williams Presta Brams Feingersh